David Sinclair and XPrize: The Challenge to Rejuvenate by 10 Years

David Sinclair and the Rejuvenation Challenge with XPrize

David Sinclair, a biologist at Harvard Medical School, envisions revolutionizing the field of human longevity. He plans to test drugs capable of rejuvenating the human body by 10 years as part of the XPrize competition. Sinclair shared his vision of a future where a simple visit to the doctor could make you look a decade younger through a specific medical prescription. MIT Technology Review revealed that Sinclair is ready to move to the next phase: human clinical trials for a "reprogramming" drug.

The XPrize competition, with a prize of $101 million, seeks to reward teams capable of "restoring" a person to a younger apparent age. Evaluation criteria include improvements in immune, cognitive, and muscular function. The grand prize will be awarded to the team demonstrating a relative improvement of 10 years or more after one year of treatment. Sinclair plans to administer a mix of oral medications to volunteers, thus seeking tangible evidence of age restoration in humans.

Five Things to Know About AI

At SXSW London, a conference titled "Five Things to Know About AI" highlighted key themes in artificial intelligence. I shared elements from our first AI10 list, an annual guide to major trends in this rapidly expanding field. In 30 minutes, I attempted to cover the key points that, in my opinion, help understand the impact of AI on the tech sector and the economy.

The five key ideas include: the omnipresence of AI, the concerns it raises, a growing negative backlash, its importance for science, and the fact that my physical presence at the conference was not necessary to convey these ideas.

Important Tech News

OpenAI has confidentially filed for an IPO in the United States, with a potential valuation reaching $1 trillion. This IPO could take place as early as September and will test investor appetite for AI companies. This move follows the IPO filings of Anthropic and SpaceX.

The United States has added BYD, Baidu, Alibaba, and others to a list of companies linked to the Chinese military, thereby limiting their operations in the U.S. The new additions also include the humanoid company Unitree.

Apple has finally unveiled a redesign of Siri, promising a more conversational assistant with a standalone app and screen-reading features, after two years of delays.

The White House and Congress are working to limit state laws on AI in favor of federal legislation, a divisive issue among American politicians.

Meta has launched a "workforce academy" for data center construction, guaranteeing employment after a free five-week program. This comes shortly after Meta laid off 8,000 employees.

Taiwan is considering restrictions on AI chip exports to China, aligning its controls with U.S. restrictions. Future AI chips could be made from glass.

Meta has quietly removed facial recognition code from its smart glasses app, a discovery made by investigators.

Humanoid robots are moving closer to the battlefield, with both the U.S. and Chinese armies pursuing this technology.

The first wind-powered underwater data center has been launched, using less energy and water than its land-based counterparts.

You could benefit from some sleep advantages without having to fall asleep if the new brain stimulation works as well on humans as it does on mice.

Quote of the Day

Clara Shih, former AI executive at Salesforce and Meta, told the New York Times: “You’re on the train, but you know there’s no destination.” She emphasizes that AI training cannot keep pace with the rapid advancements in the field.

Advances in Biotechnology

Scientists are exploring the creation of human sex cells in the lab, a radical approach to reproduction. They have already succeeded in creating artificial eggs and sperm from mouse cells, which were used to produce mouse offspring. Artificial human sex cells represent the next step, promising to end infertility while raising significant scientific and ethical challenges.